Anzeige
Mehr »
Freitag, 07.08.2026 - Börsentäglich über 12.000 News
SalesCloser Technologies: Facebook, YouTube, Instagram, WhatsApp oder TikTok!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CWA4 | ISIN: GB00BMCLYF79 | Ticker-Symbol: 88Q
Xetra
05.08.26 | 14:27
5,500 Euro
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
4BASEBIO PLC Chart 1 Jahr
5-Tage-Chart
4BASEBIO PLC 5-Tage-Chart
RealtimeGeldBriefZeit
5,4506,80008:16
Xetra-Umsätze heute
UhrzeitAktienkursStück

Keine Umsätze verfügbar.

Tagesumsatz Xetra-
0

 Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.

Aktuelle News zur Aktie 4BASEBIO PLC

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
22.07.4basebio Plc - Grant of Options & Director/PDMR Dealing3484basebio Plc - Grant of Options & Director/PDMR Dealing PR Newswire LONDON, United Kingdom, July 22 4basebio PLC ("4basebio"...
► Artikel lesen
08.07.4basebio Plc - Director Appointment5654basebio Plc - Director Appointment PR Newswire LONDON, United Kingdom, July 08 4basebio PLC ("4basebio" or the "Company") ...
► Artikel lesen
4BASEBIO Aktie jetzt für 0€ handeln
30.06.4basebio Plc - Result of AGM & Issue of Options3984basebio Plc - Result of AGM & Issue of Options PR Newswire LONDON, United Kingdom, June 30 4basebio PLC ("4basebio"...
► Artikel lesen
16.06.4basebio Plc - Notice of Investor Presentation3934basebio Plc - Notice of Investor Presentation PR Newswire LONDON, United Kingdom, June 16 4basebio...
► Artikel lesen
15.06.IN BRIEF: 4basebio appoints Jeff Coller to Strategic Advisory Board1
Weiter >>
42 Nachrichten in den letzten 12 Monaten
Das könnte Sie auch interessieren
ZeitAktuelle NachrichtenMedien
08:10Bavarian Nordic A/S: Bavarian Nordic Receives European Commission Approval of Mpox/Smallpox Vaccine for Children Aged 2 to Less than 12 YearsMVA-BN approval expanded to include children aged 2 to less than 12 years for protection against mpox, smallpox and disease caused by vaccinia virusApproval further strengthens MVA-BN's position in...
► Artikel lesen
DoAttovia Therapeutics, Inc.: Attovia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional SharesSAN CARLOS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Attovia Therapeutics, Inc. ("Attovia") (Nasdaq: ATTO), a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for...
► Artikel lesen
DoOculis Holding AG: Oculis Reports Q2 2026 Financial Results and Provides Company UpdateZUG, Switzerland, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Company pivot to neuro-ophthalmology continues with Privosegtor positioned as lead late-stage asset through the registrational PIONEER program with...
► Artikel lesen
DoSurrozen, Inc.: Surrozen Reports Second Quarter 2026 Financial Results and Provides Business UpdatePlanned IND submission for SZN-8141 in diabetic macular edema by the end of the third quarter of 2026 Expect to initiate SZN-8141 Phase 1b/2a study, DUET, by year-end 2026 with initial data anticipated...
► Artikel lesen
DoCellectis Reports Financial Results for the Second Quarter 2026Lasme-cel: Pivotal Phase 2 in r/r B-ALL (BALLI-01) FDA RMAT designation received for lasme-cel Full Phase 1 clinical data from the BALLI-01 trial presented at EHA 2026 Pivotal Phase 2 first interim...
► Artikel lesen